Journal article
IRAK4 kinase Activity is Required for Th17 Differentiation and Th17-mediated Disease
The Journal of immunology (1950), Vol.183(1), pp.568-577
07/01/2009
DOI: 10.4049/jimmunol.0802361
PMCID: PMC3638260
PMID: 19542468
Abstract
Both IL-23- and IL-1-mediated signaling pathways play important roles in Th17 cell differentiation, cytokine production, and autoimmune diseases. The IL-1 receptor associated kinase 4 (IRAK4) is critical for IL-1/TLR signaling. We show here that inactivation of IRAK4 kinase in mice (IRAK4 KI) results in significant resistance to experimental autoimmune encephalomyelitis (EAE) due to a reduction in infiltrating inflammatory cells into the CNS and reduced antigen-specific CD4
+
T cell-mediated IL-17 production. Adoptive transfer of MOG
35-55
-specific IRAK4 KI Th17 cells failed to induce EAE in either wild-type or IRAK4 KI recipient mice, indicating the lack of autoantigen-specific Th17 cell activities in the absence of IRAK4 kinase activity. Furthermore, the absence of IRAK4 kinase activity blocked induction of IL-23 receptor expression, STAT3 activation by IL-23, and Th17 cytokine expression in differentiated Th17 cells. Importantly, blockade of IL-1 signaling by IL-1RA inhibited Th17 differentiation and IL-23-induced cytokine expression in differentiated Th17 cells. The results of these studies demonstrate that IL-1-mediated IRAK4 kinase activity in T cells is essential for induction of IL-23 receptor expression, Th17 differentiation, and autoimmune disease.
Details
- Title: Subtitle
- IRAK4 kinase Activity is Required for Th17 Differentiation and Th17-mediated Disease
- Creators
- Kirk A Staschke - Eli Lilly and CompanySucai Dong - Eli Lilly and CompanyJoy Saha - Eli Lilly and CompanyJingyong Zhao - Eli Lilly and CompanyNathan A Brooks - Eli Lilly (United States)Deena L Hepburn - Eli Lilly and CompanyJinqi Xia - Eli Lilly (United States)Muhammet F Gulen - Cleveland ClinicZizhen Kang - Cleveland ClinicCengiz Z Altuntas - Cleveland ClinicVincent K Tuohy - Case Western Reserve UniversityRaymond Gilmour - Eli Lilly and CompanyXiaoxia Li - Case Western Reserve UniversitySongqing Na - Eli Lilly and Company
- Resource Type
- Journal article
- Publication Details
- The Journal of immunology (1950), Vol.183(1), pp.568-577
- DOI
- 10.4049/jimmunol.0802361
- PMID
- 19542468
- PMCID
- PMC3638260
- NLM abbreviation
- J Immunol
- ISSN
- 0022-1767
- eISSN
- 1550-6606
- Grant note
- P01 HL029582 || HL / National Heart, Lung, and Blood Institute : NHLBI
- Language
- English
- Date published
- 07/01/2009
- Academic Unit
- Pathology; Iowa Neuroscience Institute
- Record Identifier
- 9984201122202771
Metrics
30 Record Views